InvestorsHub Logo
Followers 58
Posts 10142
Boards Moderated 1
Alias Born 09/21/2016

Re: falconer66a post# 167514

Wednesday, 10/03/2018 3:08:43 PM

Wednesday, October 03, 2018 3:08:43 PM

Post# of 462128

All of that will change rather dramatically when positive results appear in the upcoming Anavex 2-73 trial in Australia. Last-century perspectives on Alzheimer’s causes and treatments will necessarily be discarded

falconer66a W/all respect I understand you know the science but I have lived w/mismanaged-no accountability-no agency ownership long enough. If they helped or added value I would acknowledge the effort.

I certainly hope you are right. I have not studied every aspect of the new PM process but I will eventually. The point I am trying to make is of course the FDA process that allowed continued testing was either miss managed or broken as it allowed/facilitated continued testing of the Amyloid thesis even after evidence was presented of patients with Amyloid but not AD. Numerous contradictory events/results were dismissed, the opposite of the Fleming AAHHHAA moment.

If no one is going to evaluate what happened in public then we will never know. As Xena might say (and she might be right) it was all part of the evergreen effort.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News